Anti-cd28 x anti-psma antibodies
US-2025388704-A1 · Dec 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Zwolak Adam patents
Zwolak Adam is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Zwolak Adam |
| Total patents | 35 |
| First publication | Nov 16, 2017 |
| Latest publication | Dec 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Enhanced protein compositions
US-2025368756-A1 · Dec 4, 2025 · US
Proteins comprising CD3 antigen binding domains and uses thereof
US-12460001-B2 · Nov 4, 2025 · US
Anti-CD28 x anti-PSMA antibodies
US-12378326-B2 · Aug 5, 2025 · US
Anti-CD28 x anti-PSMA antibodies
US-12365743-B2 · Jul 22, 2025 · US
Biosynthetic bioparatopic or bispecific binding molecules with enhanced effector functions
US-2025230254-A1 · Jul 17, 2025 · US
Gprc5d antibodies with enhanced effector function and uses thereof
US-2025188163-A1 · Jun 12, 2025 · US
Multispecific antibodies and uses thereof
US-2025188181-A1 · Jun 12, 2025 · US
Proteins comprising cd3 antigen binding domains and uses thereof
US-2025145711-A1 · May 8, 2025 · US
Stabilized cd3 antigen binding agents and methods of use thereof
US-2025136688-A1 · May 1, 2025 · US
Recent patents
Latest publications not already listed above.
Multispecific antibodies and uses thereof
US-2025136672-A1 · May 1, 2025 · US
Multispecific antibodies and uses thereof
US-2025129144-A1 · Apr 24, 2025 · US
ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES
US-2025122299-A1 · Apr 17, 2025 · US
Gucy2c antibodies and uses thereof
US-2025066510-A1 · Feb 27, 2025 · US
Biosynthetic monovalent binding molecules with enhanced effector functions
US-2025011454-A1 · Jan 9, 2025 · US
Materials and methods for multidirectional biotransportation in virotherapeutics
US-12134658-B2 · Nov 5, 2024 · US
Proteins comprising CD3 antigen binding domains and uses thereof
US-12084501-B2 · Sep 10, 2024 · US
Anti-cd28 x anti-psma antibodies
US-2024218082-A1 · Jul 4, 2024 · US
Materials and methods of using engineered ligands
US-11952411-B2 · Apr 9, 2024 · US
Proteins comprising delta-like ligand 3 (dll3) antigen binding domains and their uses
US-2024025992-A1 · Jan 25, 2024 · US
Proteins comprising HLA-G antigen binding domains and their uses
US-11827708-B2 · Nov 28, 2023 · US
Anti-cd28 x anti-psma antibodies
US-2023322961-A1 · Oct 12, 2023 · US
Anti-cd28 x anti-psma antibodies
US-2023265218-A1 · Aug 24, 2023 · US
Proteins comprising cd3 antigen binding domains and uses thereof
US-2023040715-A1 · Feb 9, 2023 · US
Materials and methods for polymeric antibody receptor targeting
US-2023019640-A1 · Jan 19, 2023 · US
Proteins comprising cd3 antigen binding domains and uses thereof
US-2022411504-A1 · Dec 29, 2022 · US
Biosynthetic glycoprotein populations
US-2022356266-A1 · Nov 10, 2022 · US
Materials and methods for multidirectional biotransportation
US-2022324970-A1 · Oct 13, 2022 · US
Materials and methods of using engineered ligands
US-2022056104-A1 · Feb 24, 2022 · US
Proteins comprising hla-g antigen binding domains and their uses
US-2022033505-A1 · Feb 3, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Janssen Biotech Inc | 30 |
| Xencor Inc | 7 |
| Janssen Pharmaceutica Nv | 3 |
| Genmab As | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 27 |
| C07K2317/92 | 23 |
| A61K2039/505 | 23 |
| C07K16/2809 | 22 |
| A61P35/00 | 22 |